Recombinant multi-species STK38 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STK38 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the AGC serine/threonine kinase family of proteins. The kinase activity of this protein is regulated by autophosphorylation and phosphorylation by other upstream kinases. This protein has been shown to function in the cell cycle and apoptosis. This protein has also been found to regulate the protein stability and transcriptional activity of the MYC oncogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
The Alternative Names of target: 5830476G13Rik,9530097A09Rik,NDR,NDR1,NDR1 protein kinase,Ndr1,Nuclear Dbf2-related kinase 1,STK38,Serine/threonine-protein kinase 38,Stk38
Go
to STK38 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T03581-Ag-1/ GM-Tg-hg-T03581-Ag-2 | Human STK38 protein | Human |
| GM-Tg-rg-T03581-Ag-1/ GM-Tg-rg-T03581-Ag-2 | Rat STK38 protein | Rat |
| GM-Tg-mg-T03581-Ag-1/ GM-Tg-mg-T03581-Ag-2 | Mouse STK38 protein | Mouse |
| GM-Tg-cynog-T03581-Ag-1/ GM-Tg-cynog-T03581-Ag-2 | Cynomolgus/Rhesus macaque STK38 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T03581-Ag-1/ GM-Tg-felg-T03581-Ag-2 | Feline STK38 protein | Feline |
| GM-Tg-cang-T03581-Ag-1/ GM-Tg-cang-T03581-Ag-2 | Canine STK38 protein | Canine |
| GM-Tg-bovg-T03581-Ag-1/ GM-Tg-bovg-T03581-Ag-2 | Bovine STK38 protein | Bovine |
| GM-Tg-equg-T03581-Ag-1/ GM-Tg-equg-T03581-Ag-2 | Equine STK38 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T03581-Ag-1/ GM-Tg-hg-T03581-Ag-2;
GM-Tg-rg-T03581-Ag-1/ GM-Tg-rg-T03581-Ag-2;
GM-Tg-mg-T03581-Ag-1/ GM-Tg-mg-T03581-Ag-2; GM-Tg-cynog-T03581-Ag-1/ GM-Tg-cynog-T03581-Ag-2; GM-Tg-felg-T03581-Ag-1/ GM-Tg-felg-T03581-Ag-2; GM-Tg-cang-T03581-Ag-1/ GM-Tg-cang-T03581-Ag-2; GM-Tg-bovg-T03581-Ag-1/ GM-Tg-bovg-T03581-Ag-2; GM-Tg-equg-T03581-Ag-1/ GM-Tg-equg-T03581-Ag-2 |
| Products Name | STK38 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | STK38 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STK38 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.